Engaging in clinical trials presents a multifaceted opportunity for medical professionals, allowing them to:
In the United States, conducting a clinical study necessitates obtaining approvals from both the FDA (Food and Drug Administration) and the IRB (Institutional Review Board). These essential green lights are mandatory prerequisites for commencing a clinical trial and are bestowed in adherence to the pertinent legal framework. Only upon securing these approvals can the initiation of a clinical trial proceed in accordance with regulatory standards.
ARENSIA's dedicated research clinics serve as the exclusive venues for conducting clinical studies. To ensure the highest standards, our research centers undergo regular inspections and audits, an ongoing commitment to uphold and enhance the quality of their work.
Clinical trials are marked by rigorous patient inclusion and exclusion criteria, intricately woven into study designs that demand meticulous adherence and flawless execution of the established research protocol. The screening failure rate in these studies typically hovers at 2 in 3, occasionally reaching a formidable 9 in 10, underscoring the precision required for determining patient eligibility.
In such circumstances, the identification of suitable patients requires a significant investment of effort, particularly in phase I and II trials compared to their phase III and IV counterparts. Engaging a diverse array of physicians becomes imperative to expedite the search and selection of eligible patients, acknowledging the pivotal role they play in navigating the complexities of patient recruitment.
Accelerating patient recruitment is paramount to ensuring the swift progress of the drug development process, thereby facilitating humanity's access to novel therapies with utmost diligence.
A physician expressing interest in collaborating with the ARENSIA research clinic, in the capacity of a "collaborating" physician, assumes a role distinct from that of a "research" physician in a clinical trial. Upon a patient's expression of intent to participate in the trial through the signing of the informed consent form, the collaborating physician, with the patient's endorsement, initiates communication with the ARENSIA team of research doctors. This collaboration encompasses the exchange of information, a thorough review of the participant's medical documentation, and regular updates on the patient's condition throughout the clinical trial. Importantly, no further involvement in the practical execution of the trial is required from the collaborating physician, and their physical presence at the ARENSIA research clinic is not mandatory.
ARENSIA highly values the inclusion of new colleagues, especially medical doctors, in its research teams. If a collaborating physician expresses interest in assuming the additional role of a research physician in a clinical trial at the ARENSIA clinic, they must undergo a comprehensive training program. This program involves dedicated time spent at the ARENSIA clinic to acquire the requisite research skills essential for fulfilling the responsibilities of a research physician. The commitment to this training underscores ARENSIA's unwavering dedication to maintaining a high standard of expertise within its esteemed research teams.
Inclusion and exclusion criteria serve as stringent patient selection requirements, tailored to the disease type and course relevant to each research project. These criteria, devised by specialists, stem from intricate scientific and statistical considerations, shaped by the composition of the new drug and the structure of the research protocol.
For physicians exploring collaboration with ARENSIA's research clinic, comprehensive information on the primary inclusion and exclusion criteria is provided, along with details on broader study aspects such as the research clinic, the team of researchers, and the list of examinations to be completed by the patient.
Empowered with this information, physicians can assess whether their patients might be potential candidates for participation in specific research clinical programs, presenting them with the opportunity to benefit from such initiatives.
Upon identifying interested patients, physicians can reach out to ARENSIA's research team for more detailed information and arrange an in-person meeting at the company's research clinic, fostering a collaborative and informed approach to patient involvement in clinical research.
The administration of any pharmaceutical, whether available in pharmacies or undergoing research, inherently carries certain risks. By the time clinical trials progress to the patient-testing stage, the associated risks are well-known and deemed either minimal or acceptable. Information about potential risks is derived from prior clinical studies involving similar components, such as dizziness, diarrhea, or nausea.
Prior to a patient consenting to participate in clinical trials and endorsing the relevant agreement, research doctors meticulously outline all conceivable risks, emphasizing potential discomfort or deterioration in well-being during the research process.
Clinical trials are conducted with vigilant oversight, ensuring patients are continuously monitored by a dedicated team of doctors ready to respond promptly to any negative changes in the patient's well-being. Rigorous protocols involve constant surveillance of vital signs and laboratory examinations, guaranteeing patient safety and providing real-time insights into their condition. This meticulous approach not only enhances patient safety but also ensures the acquisition of current and accurate information throughout the research process.
After the study is concluded, the patient continues under the care of their attending ("collaborating") physician. If there is a new study, the ARENSIA team will not directly contact the patient but will communicate solely through their physician.
This website uses cookies
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about the traffic in our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. Detailed information about the use of necessary cookies, which are essential to browse this website, and optional cookies, which you can select below, and how you can review or withdraw your consent at any time can be found in our Privacy Statement.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
This essential functionality ensures that your choices regarding data privacy and personalization are respected and consistently applied during your visits. You can seamlessly navigate our website with the confidence that your selected settings are in place, providing a tailored and secure user experience.
This cookie is an advanced component of our website, meticulously designed to track and manage the specific categories of cookies you allow. This innovative functionality ensures that your customized cookie settings are precisely implemented, offering a seamless and personalized browsing experience that aligns with your privacy preferences.
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
We create pseudonymous user profiles with the help of Google Analytics in order to design our websites in line with requirements. Google Analytics uses targeting cookies that are stored on your end device and can be read by us. In this way, we are able to recognize and count returning visitors and find out how often our websites are accessed by different users. Data processing is carried out on the basis of Art. 6 para. 1 lit. a) GDPR (consent) and § 25 para. 1 TDDDG. The information generated by the cookie about your use of our website is usually transmitted to a Google server in the USA and stored there. However, since we have activated IP anonymization on our website, your IP address will be shortened by Google beforehand within member states of the European Union. Only in exceptional cases will the full IP address be transmitted to a Google server in the USA and only shortened there (further information on the purpose and scope of data collection can be found, for example, at https://policies.google.com/privacy?hl=de&gl=de). We have also concluded an order processing contract with Google LLC (USA) in accordance with Art. 28 GDPR. Google will therefore only use all information strictly for the purpose of evaluating the use of our websites for us and compiling reports on website activity.
This cookie is used by Google Analytics to persist session state.
This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports.
We use Hotjar Observe, a service provided by Hotjar Ltd, 3 Lyons Range, 20 Bisazza Street, Sliema SLM 1640, Malta, on our website. This is a software for the analysis and optimization of online offers on the basis of pseudonymous measurements and analyses of user behavior, which may include in particular A/B tests (measurement of the popularity and user-friendliness of different content and functions), measurement of click paths and interaction with content and functions of the online offer (so-called heat maps and recordings). The legal basis is your consent in accordance with Art. 6 para. 1 lit. a) GDPR and Section 25 para. 1 TDDDG.
Set when a user first lands on a page. Ensures data from subsequent visits to the same site are attributed to the same user ID. Persists the Hotjar User ID which is unique to that site. Hotjar does not track users across different sites.
Holds current session data. Ensures subsequent requests in the session window are attributed to the same session.
We use the advertising services of ZoomInfo for our website. The service provider is the Canadian company ZoomInfo Technologies LLC, 805 Broadway, Suite 900, Vancouver, WA 98660, Canada. Your data may also be processed in Canada and thus outside the scope of the GDPR. The European Commission has decided that there is an adequate level of protection for commercial offers from Canada in accordance with Art. 45 para. 1 GDPR. This means that data transfer to this country is permitted.
This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.
First-party cookie set by ZoomInfo to identify unique visitors.
The _cfuvid cookie is used to allow the Cloudflare WAF to distinguish individual users who share the same IP address. Visitors who do not provide the cookie are likely to be grouped together and may not be able to access the site if there are many other visitors from the same IP address.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Our website uses the “LinkedIn Insight Tag” conversion tool from LinkedIn Ireland Unlimited Company, Wilton Place, Dublin 2, Ireland.This tool creates a cookie in your web browser, which enables the following data to be collected: IP address, device and browser characteristics and page events (e.g. page views). This data is encrypted, anonymized within seven days and the anonymized data is deleted within 90 days. LinkedIn does not share any personal data with us, but offers anonymized reports on the website target group and display performance. LinkedIn also offers the option of retargeting via the Insight Tag.
Used to store information about the time a sync with the lms_analytics cookie took place for users in the Designated Countries.
Used to store guest consent to the use of cookies for non-essential purposes
Facilitates data center selection.
This cookie is used to track visitors so that more relevant ads can be presented based on the visitor's preferences.
Used for remembering that a logged in user is verified by two factor authentication and has previously logged in.
Browser Identifier cookie to uniquely identify devices accessing LinkedIn to detect abuse on the platform .
Used to make a probabilistic match of a user's identity.